Connect Biopharma Holdings Limited Rings the Opening Bell in Celebration of its IPO

ABOUT THIS EVENT

Connect Biopharma Holdings Limited (“Connect Biopharma”) (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T-cell-driven research, rings the Nasdaq Opening Bell remotely from across the country and China.

Zheng Wei, PhD, Co-Founder and CEO, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.